BRIEF-VBI Vaccines to continue Phase I Trial of its CMV Vaccine Candidate

Mon Aug 22, 2016 8:58am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 22 (Reuters) - Vbi Vaccines Inc

* Data safety monitoring board has no objection to co continuing enrollment in phase i clinical study to evaluate preventative cytomegalovirus vaccine candidate

* Says will continue to share clinical trial safety data with Health Canada periodically throughout study Source text for Eikon: Further company coverage: